MitoRx Therapeutics grabs seed
MitoRx Therapeutics, a developer of novel therapeutics that reverse mitochondrial dysfunction, has secured an undisclosed amount of seed funding.
MitoRx Therapeutics, a developer of novel therapeutics that reverse mitochondrial dysfunction, has secured an undisclosed amount of seed funding.
Copyright PEI Media
Not for publication, email or dissemination